Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. L...

FDA Recall #D-0208-2025 — Class III — January 16, 2025

Recall #D-0208-2025 Date: January 16, 2025 Classification: Class III Status: Completed

Product Description

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Reason for Recall

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Recalling Firm

Appco Pharma LLC — Piscataway, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

1380 bottles

Distribution

Nationwide USA.

Code Information

Lot #: 2402101UR, Exp 02/28/2027

Status

Completed

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls